Lisuride hydrogen maleate
From Wikipedia, the free encyclopedia
| Image:Lisuride hydrogen maleate.png | |
|
Lisuride hydrogen maleate
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | 18016-80-3 |
| ATC code | N04BC10 |
| PubChem | 5282421 |
| Chemical data | |
| Formula | C24H30N4O5 |
| Mol. weight | 454.519 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Lisuride hydrogen maleate is a semi-synthetic derivative of ergot alkaloid. (C2H5)2N-CO-HN(N-CH3)(NH)
Used to lower prolactin and, in low doses, to prevent migraine attacks. The use of lisuride as initial antiparkinsonian treatment has been advocated, delaying the need for levodopa until lisuride becomes insufficient for controlling the parkinsonian disability. Preliminary trials suggest that the dermal application of lisuride may be useful in the treatment of Parkinson's disease. Lisuride is not currently available in the US.
Pharmacological profiles: DA agonist.
Chemical name: 3-(9,10-didehydro-6-methylergoline)-8-α-yl-1,1-diethyl-urea.
[edit] Commercial Names
| Name | Country of Use |
| Arolac | France |
| Cuvalit | Germany |
| Dipergon | Greece |
| Dopergin(e) | Germany, Spain, France, China |
| Dopergine | Belgium |
| Lysenyl Forte | Czech Republic, Slovakia |
| Prolacam | Australia |
| Revanil | UK |
| Dopamine agonists (N04BC) edit |
|---|
| Apomorphine, Bromocriptine, Cabergoline, Dihydrexidine, Dihydroergocryptine mesylate, Fenoldopam, Lisuride hydrogen maleate, Pergolide, Piribedil, Pramipexole, Quinpirole, Ropinirole, Rotigotine, SKF 38393, SKF 82958 |
